Catalyst Wire Dossier Catalyst Wire Dossier

Mirabegron OCAS

mirabegron · Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mirabegron OCAS, covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder [Phase 1]

See pricing